- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05251753
Evaluation of a Novel Sutureless Drain Securement Device
Evaluation of a Novel Sutureless Drain Securement Device (K-Lock Device) and Comparison to Standard Suture-based Drain Securement Techniques
Study Overview
Detailed Description
Patients will be randomized to either A) left side K-Lock with right side suture-based technique or B) right side K-Lock with left side suture-based technique. Randomization will occur before study initiation with group A or group B being assigned to a study enrollment number.
Preoperatively:
The novel suture-less prototype device will be described and/or demonstrated to the patients, and the rationale for its development will be explained. They will have opportunity to ask questions and then they will be invited to participate in the study.
Written informed consent will be obtained.
Intraoperatively:
Surgical drains will be placed per the usual routine of the surgeon. Definitive drain fixation will occur when all of the pertinent incisions are closed and dressed. At that time, each drain will be secured according to the randomization scheme.
The amount of time it takes to secure and dress each drain will be recorded using a time-stamped video (e.g. iphone).
Postoperatively:
The time until drain removal will be recorded for both groups.
On postoperative visit(s) on which a drain is removed, patients will complete a survey about their experience with the pertinent securement method/drain site.
Feasibility and ease of use of the novel drain device will be evaluated by evaluation of video recordings, qualitative feedback obtained from surgeons and/or O.R staff and nurses that handle and observe use of the device.
Safety of the novel drain device will be evaluated by inspecting device sites for signs of skin injury at each office visit and at the time of drain removal, including photographs of drain sites immediately before and after removal. It will also be assessed by feedback obtained in the patient surveys.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Renea Jennings, BS RN
- Phone Number: 3367166709
- Email: rjenning@wakehealth.edu
Study Contact Backup
- Name: Caleb T Suggs, BS
- Phone Number: 3367134339
- Email: csuggs@wakehealth.edu
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Recruiting
- Atrium Health Wake Forest Baptist
-
Contact:
- Caleb T Suggs, BS
- Phone Number: 3367134339
- Email: csuggs@wakehealth.edu
-
Contact:
- Renea Jennings, BS RN
- Phone Number: 336-716-6709
- Email: rjenning@wakehealth.edu
-
Principal Investigator:
- Lisa David, MD MBA
-
Sub-Investigator:
- Adam J Katz, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 or older
- Patient of the Department of Plastic and Reconstructive Surgery
- Able to sign English language Consent form
- Undergoing any of the following procedures requiring placement of 2 or more drains (preferably bilateral) including: Breast reconstruction, Bilateral Breast Reduction, Abdominoplasty, Body Contour surgery (e.g. panniculectomy, brachiplasty, thighplasty)
Exclusion Criteria:
- Patients with unilateral drain placement
- Unable to sign English language consent form
- Allergy to Tegaderm Dressing
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: A K-Lock left
A) left side K-Lock with right side suture-based technique
|
Patients will be randomized to either A) left side K-Lock with right side suture-based technique or B) right side K-Lock with left side suture-based technique.
|
Experimental: B K-Lock right
B) right side K-Lock with left side suture-based technique.
|
Patients will be randomized to either A) left side K-Lock with right side suture-based technique or B) right side K-Lock with left side suture-based technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time it takes to secure and dress each drain
Time Frame: Day of Surgery
|
Time it takes to secure and dress each drain will be evaluated by evaluation of video recordings to record timestamps and documented on "K-Lock Study Outcomes" tool.
This will help determine the feasibility of using this device.
|
Day of Surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ease of Use
Time Frame: Day of Surgery
|
Ease of Use will be evaluated by data recorded on the "System Usability Scale" given to OR staff.
Data is qualitative on a scale from 1-5.
|
Day of Surgery
|
Skin Injury
Time Frame: Day of surgery to day of drain removal, estimated average = 10 days
|
Skin Injury will be evaluated by inspecting device sites for instances of skin injury at each office visit and will be recorded on "K-Lock Study Outcomes" tool.
Skin Injury will also be evaluated by quantitative feedback obtained in the "Drain Securement Survey" given to patients post-operatively.
|
Day of surgery to day of drain removal, estimated average = 10 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lisa David, MD MBA, Wake Forest University Health Sciences
- Study Director: Adam J Katz, MD, Wake Forest University Health Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00080041
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Injury
-
Marmara UniversityRecruiting
-
Owlet Baby Care, Inc.University of Utah; Louisiana State University Health Sciences Center Shreveport and other collaboratorsCompletedSkin InjuryUnited States
-
Istanbul University - Cerrahpasa (IUC)Not yet recruiting
-
Masimo CorporationCompletedFalls Injury | Pressure Ulcer | Pressure InjuryUnited States
-
Ankara Yildirim Beyazıt UniversityAnkara City Hospital BilkentEnrolling by invitationPressure Injury PreventionTurkey
-
Northwell HealthEnrolling by invitationPressure Injury | Barotrauma | Otic Barotrauma | Ear Injury | BarotitisUnited States
-
University of ZurichUniversity Hospital, ZürichCompletedScars | Burn Injury | Soft Tissue Injury | Skin Necrosis | Congenital Giant Nevus | Skin TumorsSwitzerland
-
Tepecik Training and Research HospitalDokuz Eylul UniversityNot yet recruiting
-
Yi-Syuan LaiRecruiting
-
Columbia UniversityTerminated
Clinical Trials on K-Lock
-
Xiros LtdRecruitingAcromioclavicular; DislocationUnited Kingdom
-
Regional Hospital HolstebroCompleted
-
Kaiser PermanenteCompleted
-
VA Office of Research and DevelopmentEnrolling by invitationAccidental Falls | Long-Term CareUnited States
-
University of Alabama, TuscaloosaThe University of Texas Health Science Center, Houston; Brown University; University... and other collaboratorsCompletedSleep Disorder | Dementia | Alzheimer Disease | Sleep DisturbanceUnited States
-
Claus Anders Bertelsen, PhD, MDCompleted
-
Canadian Radiostereometric Analysis NetworkActive, not recruiting
-
Kallyope Inc.RecruitingObesity | Type 2 Diabetes Mellitus (T2DM)United States
-
Kallyope Inc.CompletedObesity | Type 2 Diabetes Mellitus in ObeseUnited States